Yagiela John A
Division of Diagnostic and Surgical Sciences, University of California, Los Angeles School of Dentistry, Los Angeles, California, USA.
Compend Contin Educ Dent. 2004 Sep;25(9):697-706; quiz 708.
This article reviews 3 recent developments in anxiety and pain control with significant potential for altering dental practice. First is the introduction of articaine hydrochloride as an injectable local anesthetic. Although articaine is an amide, its unique structure allows the drug to be quickly metabolized, reducing toxicity associated with repeated injections over time. The second development is the formulation of a lidocaine and prilocaine dental gel for topical anesthesia of the periodontal pocket. This product may significantly reduce the need for anesthetic injections during scaling and root planing. Finally, the use of triazolam as an oral sedative/anxiolytic is reviewed. The recent administration of triazolam in multiple doses has extended the availability of anxiety control to many dental patients, but unknowns about the safety of the technique as practiced by some dentists remains a concern.
本文回顾了焦虑与疼痛控制方面的三项最新进展,这些进展在改变牙科实践方面具有巨大潜力。首先是引入了盐酸阿替卡因作为注射用局部麻醉剂。尽管阿替卡因是一种酰胺类药物,但其独特的结构使该药物能够快速代谢,降低了随着时间推移重复注射相关的毒性。第二项进展是配制了用于牙周袋局部麻醉的利多卡因和丙胺卡因牙科凝胶。该产品可能会显著减少在龈下刮治和根面平整过程中对麻醉注射的需求。最后,本文回顾了三唑仑作为口服镇静/抗焦虑药的使用情况。近期多次给药使用三唑仑,使许多牙科患者都能获得焦虑控制,但一些牙医实施该技术的安全性仍存在未知因素,这仍是一个令人担忧的问题。